Personal Information
Organização/Local de trabalho
New York United States
Setor
Medical / Health Care / Pharmaceuticals
Site
www.theheart.org
Sobre
theheart.org is a leader in independent cardiology news, opinions, and educational programming for cardiologists and healthcare professionals.
Marcadores
theheart.org
cardiology
aha 2010
acc 2011
esc 2011
aha 2011
tct 2011
tavi
s yusuf
revascularization
acs
clopidogrel
slideshow presentation
research highlights
hrs 2011
fame ii
diabetes
theheart.org ppt
advance
everolimus-eluting stent
sirolimus-eluting stent
enoxaparin
cardiac resynchronization
europcr 2011
altitude
partner cohort a
acute coronary syndrome
platelet inhibition
atorvastatin
myocardial infarction
ffr
renal denervation
protect-af
partner cohort b slides
statins
rivaroxaban
warfarin
emphasis-hf trial
emphasis-hf study
emphasis-hf pdf
advance trial
advance study
advance pdf
acc trial
slideshow
acute ischemic syndromes
fondaparinux
acc 2006
define
gravitas
cardiovascular risk
tct 2007
act
raft
basket-prove
closure i
polyunsaturated fatty acids
p-om3
spirit iv
paclitaxel-eluting stents
nyha
shift
acc 2008
aortic stenosis
crt
bare-metal stents
coronary artery
m leon
g stone
simvastatin
heart failure
lvef
hypertension
anglo-scandinavian
discover flow
base-acs
discern-af
prelude
isar cabg
precombat
magellan
oscar
everest ii
scientific sessions
platinum
rival
aldosterone blockade
emphasis-hf
stemi
acute myocardial infarction
staccato
xience v
twente
prasugrel
trigger pci
acute mi
angioplasty
heart disease
type 2 diabetes
heart attack
stable cad
aim-high
fast
power
pallas
tracer
saturn
romicat
einstein pe
cabg
stampede
ascert
europcr 2012
atrial fibrillation
compare ii
comfortable-ami
partner a
omt
af ablation
heart rhythm society
partner cohort b ppt
transcatheter aortic-valve implantation
placement of aortic transcatheter valve trial
stich
coronary artery disease
stroke
averroes
apixaban
clinical trial
rocket af
career achievement award
adapt-des
pfo closure
live cases
respect
tct 2012
master
trilogy-acs
stemi-radial
post
ses partner b
dessolve i and ii
miami
tavr
pc trial
munich
trilogy acs
gary. iabp shock ii
woest
esg 2012
the european society of cardiology
defacto
pure
paramount
esc 2012 congress
access eu
american heart association
key trials
aspire
tact
aha 2012
dal-outcomes
pcsk9
poseidon / scipio
phs ii
trilogy acs/arctic
umpire
lodoco
relax-ahf
opera and forward
thehear.org
pcsk9 studies
madit-rit
aristotle study
aristotle trial
aristotle pdf
dig pdf
dig trial
dig study
comfortable-ami study
comfortable-ami pdf
comfortable-ami trial
compare ii study
compare ii trial
compare ii pdf
fame ii pdf
fame ii trial
fame ii study
euraction pdf
euraction trial
euraction study
tips 2 pdf
tips 2 study
tips 2 trial
vcsqi pdf
vcsqi study
vcsqi trial
cure-af pdf
cure-af trial
cure-af study
raaft-2 study
raaft-2 trial
raaft-2 pdf
acrin/pa pdf
acrin/pa trial
acrin/pa study
ascert pdf
ascert study
ascert trial
issue-3 trial
issue-3 study
issue-3 pdf
einstein pe pdf
einstein pe trial
einstein pe study
romicat ii trial
romicat ii study
romicat ii pdf
tra 2ºp-timi 50 pdf
tra 2ºp-timi 50 trial
tra 2ºp-timi 50 study
stampede trial
stampede pdf
stampede study
tracer pdf
tracer trial
tracer study
power trial
power pdf
power study
fast study
fast trial
fast pdf
c-port e trial
c-port e study
c-port e pdf
mi freee pdf
mi freee trial
mi freee study
pallas trial
pallas pdf
pallas study
saturn pdf
saturn trial
saturn study
elevate-timi 56 pdf
elevate-timi 56 study
elevate-timi 56 trial
atlas acs
atlas acs 2 trial
atlas acs 2 study
atlas acs 2 pdf
trigger pci trial
trigger pci study
trigger pci pdf
bridge study
bridge pdf
bridge trial
thehert.org
advise trial
advise study
advise pdf
twente study
twente trial
twente pdf
staccato trial
staccato pdf
staccato study
prodigy trial
prodigy pdf
prodigy study
corp pdf
corp study
corp trial
examination trial
examination study
examination pdf
hcs pdf
hcs trial
hcs study
hcs theheart.org
tct trial
hrs trial
europcr trial
parreclose 2-acs
dal-vessel pdf
dal-vessel study
dal-vessel trial
ascot-lla pdf
ascot-lla study
ascot-lla trial
discover flow trial
discover flow pdf
discover flow study
care-hf trial
care-hf study
care-hf pdf
current oasis-7 trial
current oasis-7 study
current oasis-7 pdf
enhance trial
enhance pdf
enhance study
extract-timi 25 trial
extract-timi 25 pdf
extract-timi 25 study
accord lipid trial
accord lipid study
accord lipid pdf
everest study
everest trial
everest pdf
magellan pdf
magellan study
magellan trial
oscar trial
oscar study
oscar pdf
precombat study
precombat trial
precombat pdf
platinum trial
platinum pdf
platinum study
resolute us study
resolute ac trial
resolute ac study
resolute us trial
excellent pdf
excellent trial
excellent study
isar cabg trial
isar cabg study
isar cabg pdf
altitude study
altitude trial
altitude pdf
prelude trial
prelude study
prelude pdf
discern-af trial. discern-af study
discern-af pdf
partner trial
cohort a
partner cohort a stroke data study
partner cohort a stroke data trial
base-acs study
base-acs trial
base-acs pdf
courage pdf
courage trial
courage study
invest study
invest trial
invest pdf
protect-af pdf
protect-af study
protect-af trial
spirit iv trial
spirit iv pdf
spirit iv study
triton-timi 38 trial
triton-timi 38 study
triton-timi 38 pdf
ascend-hf pdf
ascend-hf trial
ascend-hf study
symplicity
symplicity htn-2 trial
symplicity htn-2 study
symplicity htn-2 pdf
p-om3 pdf
p-om3 study
p-om3 trial
closure i trial
closure i study
closure i pdf
basket-prove pdf
basket-prove study
basket-prove trial
raft trial
raft study
raft pdf
ascot-crp pdf
ascot-crp study
ascot-crp trial
partner cohort a trial
elderly patients
partner cohort a study
partner cohort a pdf
act trial
act study
act pdf
rival study
rival pdf
rival trial
horizons ami study
horizons ami pdf
horizons ami trial
prove-it pdf
prove-it trial
prove-it study
scd-heft trial
scd-heft study
scd-heft pdf
synergy trial
synergy study
synergy pdf
accord glucose trial
accord glucose study
accord glucose pdf
accord bp trial
accord bp pdf
accord bp study
gravitas trial
gravitas study
gravitas pdf
pure study
pure trial
pure pdf
acuity trial
acuity study
acuity pdf
allhat study
allhat trial
allhat pdf
hope pdf
hope study
hope trial
athena trial
athena pdf
athena study
acc research
acc study
ideal study
ideal trial
ideal pdf
madit-crt study
madit-crt trial
oasis-5 study
oasis-5 trial
ontarget trial
ontarget pdf
ontarget study
everest ii trial
everest ii study
edge-to-edge repair study
everest ii pdf
research esc
esc trial
tct pdf
research tct
research
aha pdf
champion trial ppt
champion trial pdf
champion study
champion trial
ascend hf
symplicity htn
ascot crp
qrs emphasis-hf
horizons-ami
sort-out 4
partner
compare
cap
isar-test 4
zilver ptx
biofreedom
tct 2010
robotically assisted pci
copps
lesson 1
cure/active a
star-heart
atoll
einstein dvt
innovate pci
plato genetic substudies
response
futura oasis-8
alpha omega trial
endovascular valve
surgery
mitraclip
aha 2009
champion–pci
champion–platform
d bhatt
angiotensin
ontarget
ramipril global endpoint
ongoing telmisartan
receptor blocker
oasis-5
factor-xa
esc 2005
antithrombotic drugs
oasis-6
safe antithrombotic agent
ventricular dyssynchrony
multicenter automatic defibrillator
ideal
lipid lowering
t pedersen
aha 2005
esc 1999
vascular disease
heart outcomes prevention evaluation
vessel revascularization
endeavor
zotarolimus
taxus stents
high-risk arterial fibrillation
hrs 2008
sh hohnloser
athena
moderate risk arterial fibrillation
chlothalidone
antihypertensive
lipid lowering treatment
percutaneous revasculation
acute catheterization and urgent intervention tria
surgical revasculation
high-risk acs
gw stone
prospective urban rural epidemiology
chronic noncommunicable diseases
societal influences
cv risk factors
left ventricular assist device
mechanical assisted circulatory support
interagency registry
k d aaronsonm
heartware
thoratec's heartmate ii
anacetrapib
cetp
cetp inhibition
c cannon
cholesteryl ester
ldl-cholesterol
residual platelet reactivity
m price
platelet-function tests
thrombosis
verifynow assay
acc 2010
accord bp
w c cushman
blood–pressure-lowering arm
glucose-lowering arm
accord glucose
synergy
acc 2004
glycoprotein
k mahaffey
esc 2008
kk teo
ace-intolerant
high-risk diabetes
transcend
cardiovascular disease
angiotensin-receptor blockers
nyha class 2-3
g bardy
scd-heft
cardiac death
amiodarone
total cholesterol
cp cannon
prove-it
pravastatin
acc2004
stents in acute myocardial infarction
horizons ami
unfractionated heparin
nyha class 2–4
omega-3 fatty acids
miocardico–heart failure
chronic heart failure
statin therapy
gissi–hf
coronary intervention
radial access
s jolly
acute coronary syndromes
femoral access
o berwanger
antioxidant n-acetylcysteine
acetylcysteine
contrast-induced nephropathy
c miller
stroke data
transcatheter aortic-valve
aats 2011
c-reactive protein
ascot-crp
ps sever
implantable cardioverter-defibrillator
ambulatory heart failure
moderate hf
a tang
resynchronization
pharmacological therapy
c kaiser
bare-metal cobalt-chromium stent
basel stent cost-effectiveness trial
basket-late
drug-eluting stents
starflex septal closure
patent foramen ovale
paradoxical embolism
transient ischemic attack
a furlan
omega-3
pufa
pr kowey
renal sympathetic
md esler
symplicity htn-2
uncontrolled hypertension
clinical effectiveness
decompensated heart failure
nesiritide
ascend-hf
r califf
s wiviott
triton-timi 38
aha 2007
prasugrel-thrombolysis
target lesion failure
everolimus-eluting stents
cad
tct 2009
inhibitor ivabradine
ivabradine
m komajda
systolic heart
sodium-potassium
esc 2010
sinoatrial node
ventricular dysfunction
resynchronization reverses remodeling
reverse
c linde
acc 2009
embolic protection
dr holmes
warfarin therapy
probe
c pepine
acc 2003
international verapamil sr-trandolapril
invest
acc 2007
w e boden
clinical outcomes
aggressive drug evaluation
courage
pci
p karjalainen
major adverse cardiovascular events
mace
bio-active-stent
patient diaries
implantable loop recorder
a verma
c napolitano
programmed electrical stimulation
brugada syndrome
icd
implanted devices
shock therapy
mortality
b powell
grafts
j mehilli
drug-eluting stenting
hc gwon
xience v/promus
excellent
cypher select
zotarolimus-eluting
resolute ac
p serruys
resolute us
novo lesions
promus element
novo coronary artery lesions
platinum scaffolding
sj park
cabg surgery
olmesartan
calcium-channel blocker.
h ogawa
calcium antagonists
a cohen
inflammatory/rheumatic diseases
ischemic stroke
active cancer
vte prophylaxis
everest
mitraclip vs surgery
mitral regurgitation
t feldman
endovascular valve edge-to-edge repair
accord lipid
lipid-lowering arm
h ginsberg
blood lipids
cardiovascular risk in diabetes
extract–timi 25
thrombolysis
low-molecular-weight heparin
thrombolysis reperfusion
myocardial infarction 25
heterozygous familial hypercholesterolemia
atherosclerotic
ezetimibe
enhance
clopidogrel optimal
s mehta
current oasis-7
antiplatelet strategy
esc 2009
nyha class 3-4 hf
care-hf
qrs
jgf cleland
f zannad
perindopril
macrovascular outcomes
indapamide
microvascular outcomes
type 2 diabetes mellitus
invasively measured fractional flow reserve
stenoses
ffrct
bon-kwon koo
noninvasive fractional flow reserve
ascot-bpla
coronary heart disease
lipid lowering arm
p sever
ascot-lla
chd
cetp inhibitor
dalcetrpib
t luscher
dal-vessel
endothelial function
source
scaar registry
des meta-analysis
subcutaneous-lead icd
vt ablation study
efs confirm
working with industry
raft.
aeds
hrs/ehra consensus statement
partner cohort b cost analysis
new orleans
excellent.
resolute
tct 2011 keynote address
bridge
advise (ffr)
partner a (qol and efficacy)
tct 2011 career achievement award
rifle steacs
partner b
san francisco
homburg cream & sugar study
cv morbidity
cv mortality
glucose tolerance
tg tolerance
u laufs
hcs
mild hf
b pitt
high-risk subgroups
eplerenone
xience v stent
everolimus drug-eluting stent
bare-metal stent
cobalt-chromium stent
primary pci
corp
colchicine for recurrent pericarditis
m imazio
mvalgimigli
dual antiplatelet therapy
intimal hyperplasia
prodigy
drug-eluting-sent implantation
aortic-valce replacement survery
l thuesen
valvular aortic stenosis
endeavor resolute
target vessel failure
drug-eluting stent
c von birgelen
nace
st elevation
transradial
transfemoral
femoral
steacs
primary angioplasty
radia
fractional flow reserve
adenosine
vasodilator
j davies
thienopyridines
ticlopidine
d angiolillo
coronary stents
undergoing surgery
cangrelor
platelet reactivity
d trenk
elective stent placement
adverse cv
coronary drug-eluting sents
statin drug
vitamin niacin
cholesterol
w boden
vascular events.
m gibswon
atlas acs 2
j mega
elevate-timi 56
thrombolysis in mi 56
escalating clopidogrel
cyp2c19 allele
coronary atherosclerosis
rosuvastatin
intravascular ultrasound
s nicholls
coronary atheroma
cv events
permanent af
sj connolly
permanent atrial fibrillation
dronedarone
post-myocardial infarction
n choudhry
mi freee
full perscription drug
arbs
aceis
free rx event economic evaluation
beta blockers
ahc 2011
t aversano
c-port e
cardiovascular patient outcomes research team elec
open-heart surgery backup
surgical ablation treatment
atrial fibrillation catheter ablation
lucas boersma
af treatment
lj appel
practice-based opportunities for weight reduction
obese people
weight loss
preventing mi
preventing stroke
vopaxar
advanced medical therapy
bariatric surgery
strock
vorapaxar
thrombin receptor antagonist
tra 2ºp-timi 50
atherothrombotic ischemic
atherosclesis
computer assisted tomography ii
symptomatic pulmonary embolism
acute symptomatic pulmonary embolism
symptomatic dvt
oral rivaroxaban
syncope of uncertain etiology
pacemaker therapy
systolic neurally mediated syncope
issue-3
accf
sts
coronary disease
traditional care
emergency department
ccta
acrin/pa
raaft-2
ntiarrhythmic drug
aad
paroxysmal recurrent af
catheter-based pulmonary vein isolation
af
irrigated unipolar rf ablation
cure-af
concomitant cardiac surgery
biopolar rf ablation
atrioventricular nodal
cardioblate
postoperative product transfusion
transfusion guidelines
blood-product use
postoperative events
cardiac operations. intraoperative product transfu
ldl-c
high-risk primary-prevention
bp
two doses of low-strength polycap
low-strength polycap
tips 2
physical-activity patterns
cardiac rehabilitation program
euraction
partners
spouses
diet
pci plus omt
ffr-guided
nhbli
freee
elevate
adopt
aha 2011 s
af c-port e
atlas
c-porte e
acrin pa
coronary
issue 3
tra 2°p – timi 50
mendelian rct
acc 2012
nobori biolimus-eluting stent
everolimus eluting
biolimus a9 eluting stent
p smits
biomatrix
l räber
gazelle in stemi
biolimus-eluting stent
acute st-elevation myocardial infarction
total mortality
left ventricular ejection fractions
m gheorghiade
heart failure congress 2012
clinical heart failure
sinus rhythm
digitalis investigation group
digoxin
dig
systemic embolism
aristotle
c granger
prevent stroke
live demonstrations
nobori biolimus stent
everolimus stents
martin leon
bioerodable polymer des
source xt
reimbursement
live demonstrations; compare ii; nobori biolimus s
ethica award 2012
simplicity htn 2
surgical valve failure
vivek y reddy
carlos morillo
raaft 2
hrs
starter
magnasafe
wpw
douglas zipes
catheter ablation
michel haϊssaguerre
watchman laa closure device
dan roden
firm ablation
riata
raed abdelhadi
debra doud
icd lead safety
confusion
memory loss
fda
statin survey
blood glucose
esc cardiology conference
esc cardiology news
esc medical congress
esc slides
esc paris
european society of cardiology
stitch slides
stitch ppt
averroes trial slides
averroes ppt
re-ly trial slides
re-ly ppt
plato trial slides
plato ppt
rocket ppt trial slides
rocket af ppt
partner cohort b trial
jupiter ppt
jupiter slides
severe aortic disease
cost analysis
partner cohort b
studies
surgical treatment for ischemic heart failure
apixaban versus acetylsalicylic acid to prevent st
aspirin
randomized evaluation of long-term anticoagulant t
re-ly
venous thromboembolism
dabigatran
warfarin alternative
theheart ppt
oral anticoagulants
thromboembolism
jupiter trial
trial rosuvastatin
platelet
plato
thienopyridine
ticagrelor
non-valvular af
stroke prevention
theheartorg ppt
aortic transcatheter valve trial
partner cohort b
aortic trial
Ver mais
- Apresentações
- Documentos
- Infográficos